| Application no. and date | 09007161.4 (espacenet) (Federated) (European Patent Register), 19991223 | | Patent/reg. no. and date | DK/EP 2112166, 20181121 | | Publication date | 20091028 | | Priority no. and date | US 113647 P, 19981223 | | EP pub. no. and date |
EP 2112166 20091028 | | Effective date | | | Applicant/owner | Pfizer Inc., 235 East 42nd Street
New York, NY 10017, US,
Amgen Fremont Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | SH/GP/157862 | | Inventor | Hanson, Douglas Charles, 3 Acorn Drive
Niantic, CT 06357, US,
Neveu, Mark Joseph, 18 Greenbriar Court
Mystic, CT 06355, US,
Mueller, Eileen Elliot, 4 Butterwick Lane
Old Lyme, CT 06371, US,
Hanke, Jeffrey Herbert, 1 Jefferson Circle
Reading, MA 01867, US,
Gilman, Steven Christopher, 118 Sill Lane
Old Lyme, CT 06371, US,
Corvalan, José Ramon, 125 Williams Lane
Foster City, CA 94404, US,
Davis, C. Geoffrey, P.O. Box 7783 Rd
Auburn, CA 95604, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Humane monoklonale antistoffer til CTLA-4 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
